biotech

Vesselon's microspheres optimize radiopharmaceuticals for targeted treatment, enhancing anti-tumor effects.

Vesselon’s novel co-formulation of gas lipid microspheres and self-assembling liposomes, targeted and activated by commercial ultrasound, would be an ideal adjunct to any of these ADC drugs.

Discover tips for guiding drug development from discovery to the clinic.

Researchers rent contract vivarium space for greater experimental control, productivity, and reproducibility when developing new therapeutics.

Explore how biomolecular processes drive health and disease.

A biotech startup called Tessera Therapeutics has made a splash with its claims about the trademarked technology. Is the excitement justified?

This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.

Taylor, formerly of the University of Louisville, is known for his discovery of and research on tumor-secreted exosomes.  

Explore the latest science shaping the healthcare sector.

Explore the future of biopharma research and development.

The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.

The biotech industry is chipping away at the obstacles standing between the lab and the dinner plate.

Scientific advances almost always have the potential to benefit human lives. In times like these, they have the power to save them.

The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.

Drew Adams will discuss his work developing therapeutics that promote remyelination for neurological diseases.

The makers of the CRISPR-based testing platform, called miSHERLOCK, say it could enable people at home or physicians in resource-limited environments to detect SARS-CoV-2—and eventually, other pathogens.

The masks contain freeze-dried, cell-free biosensors, enabling them to detect pathogens including SARS-CoV-2.

Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.

Scientifically groundless regulations could undercut the potential of gene-edited crops, much as they have with GMOs.